- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC ; volume:46 ; number:2 ; year:2018 ; pages:654-663
Cellular physiology and biochemistry ; 46, Heft 2 (2018), 654-663
- Urheber
-
Xie, Wei-Bin
Liang, Li-Hui
Wu, Kai-Ge
Wang, Le-Xing
He, Xin
Song, Cheng
Wang, Yun-Qi
Li, Yun-Hui
- DOI
-
10.1159/000488634
- URN
-
urn:nbn:de:101:1-201805033403
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xie, Wei-Bin
- Liang, Li-Hui
- Wu, Kai-Ge
- Wang, Le-Xing
- He, Xin
- Song, Cheng
- Wang, Yun-Qi
- Li, Yun-Hui
Ähnliche Objekte (12)
TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways
The State Advances, the People Retreat
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy
High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes
Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways
The State Advances, the People Retreat
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy
High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes
Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways
The State Advances, the People Retreat
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy
High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes
Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC